A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/7068 (2006.01) A61K 9/127 (2006.01) A61K 31/704 (2006.01) A61K 31/706 (2006.01)
Patent
CA 2564542
Compositions which comprise an anthracycline agent, and a cytidine analog are encapsulated in liposomal carriers. The preferred anthracycline agent is selected from the group of daunorubicin, doxorubicin, and idarubicin, while the preferred cytidine analog is selected from the group of cytarabine, gemcitabine, or 5-azacytidine. The combination of the anthracycline agent and cytidine analog encapsulated in said liposomal carriers are useful in achieving a drug retention and a sustained drug release for each therapeutic agent.
La présente invention concerne des compositions comprenant un anthracyclinique et un analogue cytidinique, encapsulés dans un vecteur intracellulaire de médicament. L'anthracyclinique est choisi dans le groupe de la daunorubicine, de la doxorubicine et de l'idarubicine, alors que l'analogue cytidinique préféré est choisi dans le groupe de la cytarabine, de la gemcitabine, ou de la 5-azacytidine. Cette combinaison ainsi encapsulée permet une rétention du médicament et une libération prolongée pour chaque agent thérapeutique.
Harasym Troy
Johnstone Sharon
Mayer Lawrence
Celator Pharmaceuticals Inc.
Fetherstonhaugh & Co.
LandOfFree
Liposomal formulations of anthracycline agents and cytidine... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Liposomal formulations of anthracycline agents and cytidine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liposomal formulations of anthracycline agents and cytidine... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1361957